Holen Sie sich die Stockscreener-App
0.00
100.00%
-3.20
Schlusskurs vom Vortag:
$3.20
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$75.50M
Einnahmen:
$709.00K
Nettoeinkommen (Verlust:
$-43.14M
KGV:
0.00
EPS:
-4.54
Netto-Cashflow:
$-20.35M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$4.75
OncoCyte Corporation Stock (OCX) Company Profile
Firmenname
OncoCyte Corporation
Sektor
Branche
Telefon
510-775-0515
Adresse
1010 Atlantic Avenue, Suite 102, Alameda, CA
Vergleichen Sie OCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCX
OncoCyte Corporation
|
0.00 | 75.50M | 709.00K | -43.14M | -20.35M | -4.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
404.21 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
599.94 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.65 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
767.33 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
335.16 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
OncoCyte Corporation Stock (OCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-28 | Eingeleitet | Lake Street | Buy |
| 2022-05-24 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-03-14 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-03-17 | Fortgesetzt | Needham | Buy |
| 2021-01-07 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-16 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-11-30 | Eingeleitet | BTIG Research | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-07-30 | Bestätigt | The Benchmark Company | Speculative Buy |
| 2020-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-06-30 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2020-06-02 | Eingeleitet | Needham | Buy |
| 2019-02-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-01-29 | Hochstufung | Janney | Neutral → Buy |
| 2018-12-19 | Fortgesetzt | Lake Street | Buy |
Alle ansehen
OncoCyte Corporation Aktie (OCX) Neueste Nachrichten
Will OncoCyte Corporation stock recover after recent drop2025 Trade Ideas & Real-Time Chart Breakout Alerts - newser.com
Volume spikes in OncoCyte Corporation stock – what they meanMarket Volume Report & Capital Efficient Trading Techniques - newser.com
Can technical indicators confirm OncoCyte Corporation’s reversal2025 Market WrapUp & Safe Capital Allocation Plans - newser.com
Is OncoCyte Corporation stock attractive for growth ETFs2025 Top Decliners & AI Driven Price Predictions - newser.com
Is OncoCyte Corporation meeting your algorithmic filter criteriaMarket Activity Report & Growth Oriented Trade Recommendations - newser.com
Oncocyte gains 6% on $10.2M private placement - MSN
Ranking OncoCyte Corporation among high performing stocks via toolsJuly 2025 Catalysts & Detailed Earnings Play Strategies - newser.com
OncoCyte Corporation stock trendline breakdown2025 EndofYear Setup & High Accuracy Trade Alerts - newser.com
What drives OncoCyte Corporation stock priceMarket Profile Overview & Investment Timing Techniques - Early Times
Is OncoCyte Corporation a good long term investmentVolume Profile Analysis & Learn the Secrets of Pro Traders - Early Times
Is OncoCyte Corporation stock attractive for ETFsDollar Strength & AI Enhanced Trading Alerts - newser.com
Using RSI to spot recovery in OncoCyte Corporation2025 Retail Activity & High Accuracy Trade Signal Alerts - newser.com
Multi asset correlation models including OncoCyte CorporationDip Buying & Short-Term Trading Alerts - newser.com
Gainers Report: What are Mirum Pharmaceuticals Inc.’s earnings expectationsJuly 2025 Trade Ideas & Safe Entry Momentum Stock Tips - خودرو بانک
What is the earnings history of OncoCyte CorporationJuly 2025 Big Picture & Free Verified High Yield Trade Plans - khodrobank.com
Stock Report: Whats the outlook for Mastech Digital Incs sectorCPI Data & High Accuracy Swing Entry Alerts - خودرو بانک
Published on: 2025-09-19 16:52:47 - newser.com
Automated trading signals detected on OncoCyte CorporationMarket Trend Summary & Community Verified Trade Signals - newser.com
Applying chart zones and confluence areas to OncoCyte CorporationIndex Update & Weekly Breakout Stock Alerts - newser.com
Visualizing OncoCyte Corporation stock with heatmaps2025 Key Lessons & Free Reliable Trade Execution Plans - newser.com
Market Review: Will OncoCyte Corporation announce a stock split2025 Big Picture & Low Drawdown Trading Strategies - خودرو بانک
Chart Watch: Whats the RSI of OncoCyte Corporation stockWeekly Stock Report & Free Community Supported Trade Ideas - خودرو بانک
Aug Setups: Is OncoCyte Corporation stock undervalued right nowEarnings Beat & Reliable Breakout Forecasts - خودرو بانک
Using Ichimoku Cloud for OncoCyte Corporation technicals2025 Risk Factors & Consistent Growth Equity Picks - newser.com
Market Recap: Can OncoCyte Corporation continue delivering strong returnsRecession Risk & Safe Entry Point Alerts - خودرو بانک
Analyzing OncoCyte Corporation with multi timeframe charts2025 Major Catalysts & Fast Gain Swing Trade Alerts - newser.com
How to read the order book for OncoCyte CorporationEarnings Miss & Consistent Growth Stock Picks - newser.com
Oncocyte corp CFO buys $200,000 in stock - MSN
Aug PreEarnings: Will OncoCyte Corporation face regulatory challenges2025 Trading Volume Trends & Community Driven Trade Alerts - khodrobank.com
S P Trends: Is OncoCyte Corporation showing insider buyingEarnings Risk Summary & Consistent Growth Equity Picks - خودرو بانک
Forecasting OncoCyte Corporation price range with options dataMarket Risk Summary & Safe Swing Trade Setup Alerts - newser.com
Highs Report: Will OncoCyte Corporation stock benefit from M A2025 Key Lessons & Detailed Earnings Play Strategies - خودرو بانک
Finanzdaten der OncoCyte Corporation-Aktie (OCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.95%
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):